BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7419013)

  • 1. Clinical and biochemical expression of the genetic abnormality in idiopathic hemochromatosis.
    Valberg LS; Lloyd DA; Ghent CN; Flanagan PR; Sinclair NR; Stiller CR; Chamberlain MJ
    Gastroenterology; 1980 Nov; 79(5 Pt 1):884-92. PubMed ID: 7419013
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.
    Lloyd DA; Adams P; Sinclair NR; Stiller CR; Valberg LS
    Can Med Assoc J; 1978 Nov; 119(9):1051-6. PubMed ID: 84705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inheritance of hemochromatosis: linkage to HLA.
    Cartwright GE; Skolnick M; Amos DB; Edwards CQ; Kravitz K; Johnson A
    Trans Assoc Am Physicians; 1978; 91():273-81. PubMed ID: 754395
    [No Abstract]   [Full Text] [Related]  

  • 5. Idiopathic hemochromatosis: a study in a large Puerto Rican family.
    Vargas CA; Rubio CE; Rodríguez-Trinidad A; Torres EA
    P R Health Sci J; 1993 Dec; 12(4):283-6. PubMed ID: 8140208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
    Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
    Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene.
    Simon M; Fauchet R; Hespel JP; Beaumont C; Brissot P; Hery B; Hita De Nercy Y; Genetet B; Bourel M
    Gastroenterology; 1980 Apr; 78(4):703-8. PubMed ID: 7353757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients.
    Piperno A; Arosio C; Fargion S; Roetto A; Nicoli C; Girelli D; Sbaiz L; Gasparini P; Boari G; Sampietro M; Camaschella C
    Hepatology; 1996 Jul; 24(1):43-6. PubMed ID: 8707280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis.
    Porto G; Vicente C; Teixeira MA; Martins O; Cabeda JM; Lacerda R; Goncalves C; Fraga J; Macedo G; Silva BM; Alves H; Justiça B; de Sousa M
    Hepatology; 1997 Feb; 25(2):397-402. PubMed ID: 9021953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic hemochromatosis: distribution analysis of six laboratory measures of iron metabolism.
    Borecki IB; Rao DC; Le Mignon L; Yaouanq J; Simon M; Lalouel JM
    Am J Med Genet; 1989 Nov; 34(3):435-41. PubMed ID: 2596531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iron metabolism and its exploration in clinical biology].
    Brissot P; Pigeon C; Moirand R; Guyader D; Mendler MH; Sapey T; Deugnier Y; Lescoat G; Loréal O
    Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():5-10. PubMed ID: 9827209
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes of idiopathic hemochromatosis is not promoted (except by chance) by diabetic heredity].
    Simon M; Alexandre JL; Fauchet R; Genetet N; Scordia C; Jollant M; Hespel JP; Bourel M
    Journ Annu Diabetol Hotel Dieu; 1978; ():33-43. PubMed ID: 651105
    [No Abstract]   [Full Text] [Related]  

  • 13. [Idiopathic hemochromatosis. A hereditary defect in the regulation of iron metabolism].
    Hauge A
    Tidsskr Nor Laegeforen; 1982 Sep; 102(26):1332-4. PubMed ID: 7164080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hereditary hemochromatosis].
    Tokarev IuN; Settarova DA
    Klin Med (Mosk); 1988 Mar; 66(3):136-42. PubMed ID: 3292825
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families.
    Adams PC; Campion ML; Gandon G; LeGall JY; David V; Jouanolle AM
    Hepatology; 1997 Oct; 26(4):986-90. PubMed ID: 9328324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-linked iron overload and myopathy in maintenance hemodialysis patients.
    Bregman H; Gelfand MC; Winchester JF; Manz HJ; Knepshield JH
    Trans Am Soc Artif Intern Organs; 1980; 26():366-8. PubMed ID: 7245514
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-linked hemochromatosis and other forms of iron overload.
    Bloom PD; Gordeuk VR; MacPhail AP
    Dermatol Clin; 1995 Jan; 13(1):57-63. PubMed ID: 7712651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Family screening strategy for genetic hemochromatosis].
    Deugnier Y; Fauchet R; Brissot P
    Gastroenterol Clin Biol; 1990; 14(8-9):662-8. PubMed ID: 2227239
    [No Abstract]   [Full Text] [Related]  

  • 19. Percent transferrin saturation in segregating hemochromatosis.
    Borecki IB; Rao DC; Yaouanq J; Lalouel JM
    Am J Med Genet; 1990 Jul; 36(3):301-5. PubMed ID: 2363427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemochromatosis: current concepts and management.
    Crosby WH
    Hosp Pract (Off Ed); 1987 Feb; 22(2):173-7, 181-92. PubMed ID: 3100563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.